• Lucid Diagnostics held its annual shareholder meeting on June 24, 2026.
• Shareholders backed an amendment to lift authorized common shares by 100 million, taking the total to 400 million; the amendment was filed and took effect June 24, 2026.
• Shareholders ratified CBIZ CPAs as independent registered public accounting firm for the year ending Dec. 31, 2025.
• Shareholders re-elected three Class B directors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lucid Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-029943), on June 24, 2026, and is solely responsible for the information contained therein.